Failed early
Glatiramer acetate: slow disability worsening in relapsing and progressive MS
relapsing and progressive MS · Glatiramer acetate
Controlled phase 2 trials were negative.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 0
Deciding trials (phase 2): 0 met, 1 did not.
Other linked trials: 0
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
- Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)decides the statusStopped: not working
Phase 2 · 2021 · Placebo-controlled · MSFT-NCT04079088
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-27First listed as Failed early
Related hypotheses
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error